Luciana Jelisaveta Giambarberi, MD
Psychiatry · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Research they published
2 papers · cited 9 times
Published as Luciana Giambarberi at Stanford Medicine, Stanford University.
Research identity is not a guarantee of current clinical practice. Other people publish under this name, so only papers written from a hospital or school on this record are counted. The real total may be higher. Same name is not the same person — if this looks like someone else, tell us.
| 2025 | Annual Course / From Then to Now: The Evolving Spectrum of Epilepsy Care | Epiliepsy currents/Epilepsy currents |
| 2024 | A Web-Based Educational Module Using Clinical Neuroscience to Deliver the Diagnosis of Functional Neurological Disorder | Journal of Neuropsychiatry |
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Giambarberi’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$6,345
Medicare paid this office $6,345 for 26 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 21 | $3,274 | $78 |
Who their Medicare patients are
26 Original Medicare patients in 2024. Average age 48 · Women 42% · Health risk score 1.31. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 58%.
The office billed $24,350, Medicare allowed $9,136 and paid $6,345; for 78 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 26 | 78 | 48 | 1.31 | $24,350 | $6,345 |
| 2023 | 27 | 197 | 53 | 1.11 | $67,087 | $17,792 |
| 2022 | 37 | 159 | 53 | 1.13 | $52,143 | $13,297 |
| 2021 | 36 | 119 | 51 | 1.47 | $28,283 | $8,062 |
| 2020 | 52 | 144 | 54 | 1.32 | $35,060 | $10,424 |
| 2019 | 42 | 58 | 58 | 1.21 | $17,294 | $5,198 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 22 | $7,444 | $86 |
| Long return visit (40+ min) | 13 | $4,757 | $125 |
2022: 1 service
| Return visit (30+ min) | 22 | $5,386 | $80 |
2021: 2 services
| Telephone medical discussion with physician, 21-30 minutes | 11 | $3,131 | $87 |
| Return visit (30+ min) | 20 | $2,696 | $84 |
2020: 2 services
| Telephone medical discussion with physician, 21-30 minutes | 15 | $4,808 | $81 |
| Return visit (30+ min) | 26 | $2,311 | $75 |
2019: 1 service
| Return visit (30+ min) | 35 | $3,476 | $83 |
Medicaid work
$14,634 in 2024
Medicaid paid $14,634 for 262 billed services this clinician did in 2024, up to 53 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 246 | $14,424 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 16 | $210 |
| 2024 | 262 | 2 | 53 | $14,634 |
| 2023 | 537 | 3 | 40 | $31,189 |
| 2022 | 302 | 2 | 22 | $21,796 |
| 2021 | 119 | 3 | 18 | $10,188 |
| 2020 | 138 | 4 | 16 | $5,181 |
| 2019 | 14 | 1 | 13 | $495 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 427 | $23,193 |
| Psychiatric diagnostic evaluation with medical services | 74 | $7,931 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 36 | $65 |
2022
| Return visit (30+ min) | 208 | $12,850 |
| Psychiatric diagnostic evaluation with medical services | 94 | $8,945 |
2021
| Psychiatric diagnostic evaluation with medical services | 71 | $6,893 |
| Return visit (30+ min) | 34 | $2,356 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 14 | $939 |
2020
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 37 | $2,241 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 59 | $1,235 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 28 | $1,198 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 14 | $507 |
2019
| Return visit (30+ min) | 14 | $495 |
Drugs they prescribed that Part D paid
$14,489
Pharmacies billed $14,489 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 447) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
439 generic and fewer than 11 brand-name prescriptions · $14,489 in drug cost · 21 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Naltrexone | 16 | $1,367 | $85 |
| Aripiprazole | 15 | $1,060 | $71 |
| Clonazepam | 74 | $833 | $11 |
| Mirtazapine | 31 | $694 | $22 |
| Gabapentin | 30 | $641 | $21 |
See all 16 drugs
| Naltrexone | 16 | $1,367 | $85 |
| Aripiprazole | 15 | $1,060 | $71 |
| Clonazepam | 74 | $833 | $11 |
| Mirtazapine | 31 | $694 | $22 |
| Gabapentin | 30 | $641 | $21 |
| Prazosin | 19 | $493 | $26 |
| Duloxetine | 15 | $401 | $27 |
| Lamotrigine | 12 | $352 | $29 |
| Dextroamphetamine-Amphetamine | 13 | $252 | $19 |
| Quetiapine | 24 | $252 | $10 |
| Bupropion Xl | 12 | $213 | $18 |
| Hydroxyzine | 22 | $168 | $8 |
| Trazodone | 23 | $104 | $5 |
| Sertraline | 13 | $100 | $8 |
| Lorazepam | 20 | $88 | $4 |
| Alprazolam | 16 | $61 | $4 |
Year by year
| 2024 | 447 | 51 | 0% (0) | None | $14,489 |
| 2023 | 672 | 73 | 0% (0) | 6% | $29,861 |
| 2022 | 654 | 79 | 0% (0) | 5% | $33,006 |
| 2021 | 568 | 69 | 0% (0) | 3% | $24,039 |
| 2020 | 543 | 91 | 0% (0) | 6% | $41,830 |
| 2019 | 341 | 75 | 0% (0) | 9% | $34,286 |
| 2018 | 13 | None | 0% (0) | 0% | $96 |
| 2017 | 58 | 20 | 0% (0) | None | $2,767 |
| 2016 | 24 | None | 0% (0) | None | $415 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Aripiprazole | 30 | $3,382 | $113 |
| Carbamazepine Er | 15 | $2,909 | $194 |
| Naltrexone | 16 | $2,292 | $143 |
| Mirtazapine | 52 | $1,383 | $27 |
| Prazosin | 26 | $776 | $30 |
| Gabapentin | 27 | $644 | $24 |
| Clonazepam | 103 | $641 | $6 |
| Risperidone | 23 | $588 | $26 |
| Duloxetine | 35 | $521 | $15 |
| Trazodone | 35 | $510 | $15 |
| Fluvoxamine Maleate | 13 | $415 | $32 |
| Hydroxyzine | 19 | $310 | $16 |
| Dextroamphetamine-Amphetamine | 17 | $302 | $18 |
| Bupropion Xl | 11 | $293 | $27 |
| Sertraline | 21 | $260 | $12 |
| Lorazepam | 41 | $251 | $6 |
| Quetiapine | 15 | $178 | $12 |
| Alprazolam | 33 | $153 | $5 |
| Fluoxetine | 15 | $144 | $10 |
| Zolpidem | 14 | $92 | $7 |
2022: 18 drugs
| Naltrexone | 15 | $1,988 | $133 |
| Aripiprazole | 31 | $1,680 | $54 |
| Mirtazapine | 55 | $1,434 | $26 |
| Gabapentin | 31 | $1,192 | $38 |
| Clonazepam | 112 | $1,157 | $10 |
| Prazosin | 26 | $782 | $30 |
| Dextroamphetamine-Amphetamine | 29 | $721 | $25 |
| Trazodone | 25 | $578 | $23 |
| Lamotrigine | 17 | $570 | $34 |
| Duloxetine | 19 | $544 | $29 |
| Risperidone | 20 | $444 | $22 |
| Fluvoxamine Maleate | 12 | $428 | $36 |
| Methylphenidate | 12 | $413 | $34 |
| Sertraline | 29 | $381 | $13 |
| Bupropion Xl | 16 | $358 | $22 |
| Lorazepam | 25 | $216 | $9 |
| Alprazolam | 40 | $169 | $4 |
| Quetiapine | 15 | $163 | $11 |
2021: 16 drugs
| Aripiprazole | 29 | $2,357 | $81 |
| Desvenlafaxine Succinate Er | 20 | $2,152 | $108 |
| Naltrexone | 12 | $1,970 | $164 |
| Duloxetine | 28 | $1,726 | $62 |
| Clonazepam | 97 | $1,006 | $10 |
| Mirtazapine | 52 | $1,004 | $19 |
| Gabapentin | 46 | $933 | $20 |
| Alprazolam | 49 | $453 | $9 |
| Lamotrigine | 12 | $368 | $31 |
| Bupropion Xl | 11 | $358 | $33 |
| Trazodone | 20 | $335 | $17 |
| Sertraline | 15 | $334 | $22 |
| Risperidone | 12 | $281 | $23 |
| Lorazepam | 32 | $268 | $8 |
| Prazosin | 11 | $262 | $24 |
| Zolpidem | 15 | $117 | $8 |
2020: 14 drugs
| Guanfacine Hcl Er | 12 | $1,844 | $154 |
| Trazodone | 31 | $1,185 | $38 |
| Duloxetine | 21 | $989 | $47 |
| Sertraline | 44 | $634 | $14 |
| Quetiapine | 30 | $624 | $21 |
| Lamotrigine | 26 | $617 | $24 |
| Clonazepam | 64 | $558 | $9 |
| Mirtazapine | 29 | $497 | $17 |
| Gabapentin | 24 | $309 | $13 |
| Fluoxetine | 13 | $265 | $20 |
| Alprazolam | 30 | $183 | $6 |
| Escitalopram | 11 | $137 | $12 |
| Citalopram Hbr | 12 | $112 | $9 |
| Lorazepam | 20 | $97 | $5 |
2019: 11 drugs
| Bupropion Xl | 14 | $2,121 | $152 |
| Aripiprazole | 13 | $1,441 | $111 |
| Duloxetine | 21 | $815 | $39 |
| Quetiapine | 28 | $467 | $17 |
| Trazodone | 18 | $329 | $18 |
| Fluoxetine | 14 | $314 | $22 |
| Clonazepam | 25 | $295 | $12 |
| Lamotrigine | 14 | $240 | $17 |
| Escitalopram | 13 | $210 | $16 |
| Sertraline | 20 | $180 | $9 |
| Mirtazapine | 12 | $109 | $9 |
2017: 1 drug
| Clonazepam | 11 | $35 | $3 |
2016: 1 drug
| Clonazepam | 11 | $130 | $12 |
Professional record
- NPI
- 1245586551
- Licence
- NC 2018-00503
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X); Federal specialty code 2084B0040X (2084B0040X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2012-07-24
- NPI last updated
- 2025-07-01
- NPI record certified
- 2025-07-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 791 Jonestown Rd, Winston Salem, NC, 27103